Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial

Psoriasis is a chronic inflammatory skin disease with relapsing nature. Estimates are that approximately 2–3% of the world’s population suffers from this disease. More severe forms of psoriasis are conditions of high inflammation, which is confirmed by the clinical picture and numerous inflammatory...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jelena Petković-Dabić, Ivana Binić, Bojana Carić, Ljiljana Božić, Sanja Umičević-Šipka, Nataša Bednarčuk, Saša Dabić, Mirna Šitum, Snježana Popović-Pejičić, Miloš P. Stojiljković, Ranko Škrbić
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-01-01
Colecção:	Biomolecules
Assuntos:	psoriasis T2DM semaglutide PASI DLQI cytokine
Acesso em linha:	https://www.mdpi.com/2218-273X/15/1/46
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!